On February 5th at 1:00 pm, join Neeraj Salathia, Director of Advanced Genomics, for a presentation on Rapid Multi-Omics Cell Therapy Characterization and QC.
Resilience aims to translate advances in cell therapy research for patient benefit by developing a multi-omics assay platform for characterization of cell therapy products and consolidated QC release. This solution will significantly reduce manufacturing times and costs while enhancing understanding of drug product characteristics and associated patient clinical outcomes.
Don’t miss this informational presentation and the opportunity to connect with Neeraj during Precision Medicine World Conference in Santa Clara, CA!
